CH₃CH₃
official

Morpholin-3-yldiphenylmethanol (Morphodrol): general

by ch3ch3 · 8h ago · 0 comments

Morphodrol is a name used by sellers for the chemical PubChem lists as “morpholin-3-yl(diphenyl)methanol”.⁠[1] It is a close structural relative of pipradrol, a stimulant once sold as a prescription medicine, with one atom of pipradrol's ring changed. It has never been a medicine. The experiences section collects what readers have reported, which is most of what exists. This page is a summary of what is known. It is not medical advice and it gives no amounts.

What has been studied

Nothing that we could find. A PubMed search on 2026-11-21 for morphodrol, and for its chemical names, returned no records at all: no study in people, in animals or in cells.⁠[2] That means nobody has published what it does in the body, how long it lasts, how toxic it is, or how it interacts with other drugs. It does not mean it is harmless. Everything below about risks is reasoning from its relatives, and is labelled that way.

Its relatives, and what they did

The two best-documented members of the pipradrol family sold as recreational drugs are desoxypipradrol (2-DPMP) and diphenylprolinol (D2PM). A toxicology review explains that “D2PM is a pyrrolidine analogue and 2-DPMP is a desoxy analogue of pipradrol”, and that in animal studies 2-DPMP “increases the release of dopamine and decreases dopamine re-uptake comparable to the effects of cocaine”.⁠[3]

Both sent people to hospital. The first confirmed case of D2PM poisoning involved “chest pain and sympathomimetic features (hypertension and tachycardia)”, meaning high blood pressure and a racing heart, and the review concluded that for both drugs “prolonged and clinically significant neuropsychiatric symptoms have been reported”.⁠[3] In Scotland in 2010, a product sold as Ivory Wave led to “Thirty-four emergency attendances” at one hospital, with “a toxidrome which lasted several days” that included agitation, hallucinations and paranoia.⁠[4] The powder was analysed and “found to contain desoxypipradrol”, and the authors wrote: “It was associated with prolonged psychiatric symptoms as a key feature”.⁠[4]

That is the family morphodrol belongs to. A small change to a molecule can make a drug stronger, weaker or different in kind, so these cases do not tell us what morphodrol does. They are the reason not to assume it is mild.

What the reader reports suggest

The experiences section collects reports that disagree, from almost no effect to compulsive redosing and a hard comedown. Reports are not measurements, and nobody can confirm what was in any reader's powder. The Ivory Wave authors made the same point about product names in general: “Consistency of name, but with change in the content of the product, may cause harm”.⁠[4]

Stimulant risks

What follows is what the US Centers for Disease Control and Prevention says about stimulants in general, since nothing specific to morphodrol exists. The CDC notes that “not all stimulant overdoses look the same”.⁠[5] Among the signs that need medical attention it lists a fast or irregular heartbeat, overheating, high blood pressure and “chest pains or tightness”.⁠[5] Agitation, paranoia or hallucinations that do not wear off, as in the relatives above, also need medical help.

What is not known

Everything specific: its effects, duration, toxicity, interactions, and what a powder sold under the name actually contains.⁠[2]

References

  1. Morpholin-3-yl(diphenyl)methanol, PubChem compound record CID 73062393 (synonyms list) — National Center for Biotechnology Information, PubChem
  2. PubMed search for morphodrol, diphenylhydroxymethyl morpholine, or diphenyl AND morpholin-3-yl AND methanol (run 2026-11-21: 0 records) — PubMed (US National Library of Medicine)
  3. Use and acute toxicity associated with the novel psychoactive substances diphenylprolinol (D2PM) and desoxypipradrol (2-DPMP) (Wood and Dargan, Clinical Toxicology, 2012) — PubMed (US National Library of Medicine)
  4. 'Ivory wave' toxicity in recreational drug users; integration of clinical and poisons information services to manage legal high poisoning (Murray et al., Clinical Toxicology, 2012) — PubMed (US National Library of Medicine)
  5. Stimulant Guide: Overdose Prevention and Response (2024) — US Centers for Disease Control and Prevention
0

Comments

Sign in to join the conversation.

No comments yet.

Tell us something